“…Intracavernosal moxisylyte has produced success rates in 68% of patients (Buvat, BuvatHerbaut, Lemaire, & Marcolin, 1993). Despite these efficacies, long-term use of intracavernosal pharmacotherapies is poor, with dropout rates typically ranging from 50 to 80% (Barada & McKimmy, 1994;Rowland, Boedhoe, Dohle, & Slob, 1999). Reasons for discontinuation include declining sexual interest, inconvenience, cost, and preference for a less invasive form of treatment (Barada & McKimmy, 1994).…”